Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Healthcare
/
Fresenius Medical Care
FME
Fresenius Medical Care
Aging, Diabetes, And Digital Health Will Fortify Home Dialysis Care
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 17 Analysts
Published
16 Jun 25
Updated
20 Aug 25
1
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
€64.88
32.8% undervalued
intrinsic discount
20 Aug
€43.60
Loading
1Y
26.3%
7D
2.3%
Author's Valuation
€64.9
32.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
€64.9
32.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
23b
2014
2017
2020
2023
2025
2026
2028
Revenue €22.5b
Earnings €1.7b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
3.95%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
4.96%
Calculation
€1.69b
Earnings '28
x
13.00x
PE Ratio '28
=
€21.97b
Market Cap '28
€21.97b
Market Cap '28
/
293.41m
No. shares '28
=
€74.89
Share Price '28
€74.89
Share Price '28
Discounted to 2025 @ 4.95% p.a.
=
€64.78
Fair Value '25